GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Parexel International Corporation (PRXL) [hlAlert]

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With
a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.
( Total: 23 Current Stock Recommendations )
Parexel International Corporation   (23)
Sell Hold 30% Buy 65%
Related companies
China Biologic ...   (4)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (6)
Buy 100%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 40% Buy 40%
Salix ...   (31)
Hold 39% Buy 61%
Filter by Gains:   
  
Rating:
Sell PRXL
down 8.63 %

Rating:
Buy PRXL
up 38.35 %

Rating:
Buy PRXL
up 2.80 %

Rating:
Buy PRXL
up 123.94 %
Parexel International Corporation (PRXL) rated Buy by Citigroup
Tuesday,  Feb 18, 2014  8:25 AM ET

Rating:
Buy PRXL
up 40.54 %

Rating:
Buy PRXL
up 37.45 %

Rating:
Hold PRXL

Rating:
Buy PRXL
up 37.45 %

Rating:
Buy PRXL
up 41.09 %

Rating:
Buy PRXL
up 38.35 %

Rating:
Buy PRXL
up 48.82 %

Rating:
Hold PRXL

Your Recent Stocks
SymbolLastChange
PRXL 59.17 down  -14.51 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy